Simple Summary Immune checkpoint inhibitors have revolutionized cancer therapy and
improved clinical outcomes. Immunotherapy is now increasingly combined with …

Background: Thymic epithelial tumors (TET) are rare neoplasms of the anterior mediastinum.
Surgery is the mainstay treatment for resectable TET, whereas systemic treatments are …

Background Thymic epithelial tumors (TETs) are rare neoplasms arising in the mediastinum,
including thymic carcinomas and thymomas. Due to their rarity, little is known about the …

Simple Summary Similarly to other solid malignancies, there is a growing interest in testing
immune checkpoint inhibitors (ICIs) for thymic epithelial tumors (TETs). However, the thymus …

Background: Thymic carcinoma is a rare cancer with an aggressive clinical presentation and
no organotypic symptoms. Despite using platinum-based chemotherapy as first-line …

Background Thymic carcinoma, a rare malignancy in the mediastinum, currently lacks
standardized treatment options. Although surgery remains a crucial component among …

Objective The aim of this study is to describe characteristics and survival outcome of patients
who underwent surgical treatment for distant thymoma relapse according to the definition of …

Résumé Les tumeurs épithéliales thymiques sont des tumeurs rares, d'évolution et de
pronostic variables. La classification histopathologique distingue deux principaux types …